Table 2.

Crude and Propensity Score–Adjusted Difference in Costs Between Methicillin-resistant Staphylococcus aureus- and Methicillin-susceptible Staphylococcus aureus-Related Hospitalizations, 2014

Crude costs, $aPropensity score–adjusted costs, $a
MRSAMSSAMRSAMSSAP Value
Overall (n = 616070)
Septicemiaa35408 (34007–36808)34628 (33154–36102)34526 (32918–36134)34175 (32347–36002).69
Pneumoniab39589 (38048–41131)54132 (51632–56632)38561 (36811–40725)40725 (38717–42733).045
Unspecifiedc15948 (15516–16380)18977 (18262–19692)14792 (14383–15201)15578 (15079–16077)<.001
Hospitalizations with no in-hospital mortality (n = 587850)
Septicemiaa33564 (32224–34904)32440 (31157–33723)32618 (31072–34164)32170 (30585–33754).589
Pneumoniab37737 (36162–39311)52678 (50060–55296)36771 (34989–38553)39041 (37015–41066).047
Unspecifiedc15637 (15218–16057)18545 (17879–19212)14529 (14132–14926)15314 (14828–15799)<.001
Hospitalizations with no in-hospital mortality (LOS < 10 days) (n = 407040)
Septicemiaa13269 (12999–13538)14130 (13845–14416)13204 (12930–13479)13886 (13594–14177)<.001
Pneumoniab12962 (12661–13264)15483 (14871–16096)12870 (12565–13175)13763 (13266–14259).001
Unspecifiedc9131 (9009–9252)10248 (10088–10408)9106 (8981–9230)9576 (9432–9720)<.001
Crude costs, $aPropensity score–adjusted costs, $a
MRSAMSSAMRSAMSSAP Value
Overall (n = 616070)
Septicemiaa35408 (34007–36808)34628 (33154–36102)34526 (32918–36134)34175 (32347–36002).69
Pneumoniab39589 (38048–41131)54132 (51632–56632)38561 (36811–40725)40725 (38717–42733).045
Unspecifiedc15948 (15516–16380)18977 (18262–19692)14792 (14383–15201)15578 (15079–16077)<.001
Hospitalizations with no in-hospital mortality (n = 587850)
Septicemiaa33564 (32224–34904)32440 (31157–33723)32618 (31072–34164)32170 (30585–33754).589
Pneumoniab37737 (36162–39311)52678 (50060–55296)36771 (34989–38553)39041 (37015–41066).047
Unspecifiedc15637 (15218–16057)18545 (17879–19212)14529 (14132–14926)15314 (14828–15799)<.001
Hospitalizations with no in-hospital mortality (LOS < 10 days) (n = 407040)
Septicemiaa13269 (12999–13538)14130 (13845–14416)13204 (12930–13479)13886 (13594–14177)<.001
Pneumoniab12962 (12661–13264)15483 (14871–16096)12870 (12565–13175)13763 (13266–14259).001
Unspecifiedc9131 (9009–9252)10248 (10088–10408)9106 (8981–9230)9576 (9432–9720)<.001

Abbreviations: LOS, length of stay; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus.

aMean total cost (95% confidence interval).

bInternational Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) codes 038.11 and 038.12.

cICD-9 codes 482.41 and 482.42.

dICD-9 codes 041.11 and 041.12.

Table 2.

Crude and Propensity Score–Adjusted Difference in Costs Between Methicillin-resistant Staphylococcus aureus- and Methicillin-susceptible Staphylococcus aureus-Related Hospitalizations, 2014

Crude costs, $aPropensity score–adjusted costs, $a
MRSAMSSAMRSAMSSAP Value
Overall (n = 616070)
Septicemiaa35408 (34007–36808)34628 (33154–36102)34526 (32918–36134)34175 (32347–36002).69
Pneumoniab39589 (38048–41131)54132 (51632–56632)38561 (36811–40725)40725 (38717–42733).045
Unspecifiedc15948 (15516–16380)18977 (18262–19692)14792 (14383–15201)15578 (15079–16077)<.001
Hospitalizations with no in-hospital mortality (n = 587850)
Septicemiaa33564 (32224–34904)32440 (31157–33723)32618 (31072–34164)32170 (30585–33754).589
Pneumoniab37737 (36162–39311)52678 (50060–55296)36771 (34989–38553)39041 (37015–41066).047
Unspecifiedc15637 (15218–16057)18545 (17879–19212)14529 (14132–14926)15314 (14828–15799)<.001
Hospitalizations with no in-hospital mortality (LOS < 10 days) (n = 407040)
Septicemiaa13269 (12999–13538)14130 (13845–14416)13204 (12930–13479)13886 (13594–14177)<.001
Pneumoniab12962 (12661–13264)15483 (14871–16096)12870 (12565–13175)13763 (13266–14259).001
Unspecifiedc9131 (9009–9252)10248 (10088–10408)9106 (8981–9230)9576 (9432–9720)<.001
Crude costs, $aPropensity score–adjusted costs, $a
MRSAMSSAMRSAMSSAP Value
Overall (n = 616070)
Septicemiaa35408 (34007–36808)34628 (33154–36102)34526 (32918–36134)34175 (32347–36002).69
Pneumoniab39589 (38048–41131)54132 (51632–56632)38561 (36811–40725)40725 (38717–42733).045
Unspecifiedc15948 (15516–16380)18977 (18262–19692)14792 (14383–15201)15578 (15079–16077)<.001
Hospitalizations with no in-hospital mortality (n = 587850)
Septicemiaa33564 (32224–34904)32440 (31157–33723)32618 (31072–34164)32170 (30585–33754).589
Pneumoniab37737 (36162–39311)52678 (50060–55296)36771 (34989–38553)39041 (37015–41066).047
Unspecifiedc15637 (15218–16057)18545 (17879–19212)14529 (14132–14926)15314 (14828–15799)<.001
Hospitalizations with no in-hospital mortality (LOS < 10 days) (n = 407040)
Septicemiaa13269 (12999–13538)14130 (13845–14416)13204 (12930–13479)13886 (13594–14177)<.001
Pneumoniab12962 (12661–13264)15483 (14871–16096)12870 (12565–13175)13763 (13266–14259).001
Unspecifiedc9131 (9009–9252)10248 (10088–10408)9106 (8981–9230)9576 (9432–9720)<.001

Abbreviations: LOS, length of stay; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus.

aMean total cost (95% confidence interval).

bInternational Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) codes 038.11 and 038.12.

cICD-9 codes 482.41 and 482.42.

dICD-9 codes 041.11 and 041.12.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close